| #262 |
Abraham Froyman |
— |
2 |
| #262 |
Alevtina Malakova |
— |
2 |
| #262 |
William H. Mercier |
— |
2 |
| #262 |
Theodore Probst, Jr. |
— |
2 |
| #262 |
Stephen Paterson |
— |
2 |
| #262 |
Armando Meynet |
— |
2 |
| #262 |
Pauline Kra |
Columbia University |
2 |
| #262 |
Robert Tjia |
— |
2 |
| #262 |
Ursula Capasso |
— |
2 |
| #262 |
Solomon Levinson |
— |
2 |
| #262 |
Hillel Ulysses Gorelick |
— |
2 |
| #262 |
Herbert Herschlag |
— |
2 |
| #262 |
Nicholas Mihalik |
— |
2 |
| #262 |
Morton Phillips |
— |
2 |
| #262 |
Joseph S. Engenito, Jr. |
— |
2 |
| #262 |
Isadore Gepner |
Pittway |
2 |
| #262 |
Weisheng Xu |
Sloan Kettering Institute For Cancer Research |
2 |
| #262 |
Mary Lui |
The Johns Hopkins University |
2 |
| #262 |
Varun Narendra |
New York University |
2 |
| #262 |
Lev Slobodnik |
— |
2 |
| #262 |
Sheldon J. Ashley |
— |
2 |
| #422 |
Thomas Cetta |
Designs For Vision |
1 |
| #422 |
Ohannes J. Erberber |
— |
1 |
| #422 |
Joseph Vadacchino |
Trine Products |
1 |
| #422 |
Andrew F. Mulroy, Jr. |
— |
1 |
| #422 |
Michael W. Van Brackle |
— |
1 |
| #422 |
John D. Lowenthal |
— |
1 |
| #422 |
Evelyn A. Mundo-Torres |
— |
1 |
| #422 |
Regine Millien-White |
— |
1 |
| #422 |
Frank Blaha |
— |
1 |
| #422 |
Edmond M. Fischer |
— |
1 |
| #422 |
Selbourne Rose |
— |
1 |
| #422 |
Carlos E. Torres |
— |
1 |
| #422 |
Henry P. Muller |
Lightolier Division Of The Genlyte Group |
1 |
| #422 |
Sari Wacks |
IBM |
1 |
| #422 |
Mircea-Mike Gershin |
— |
1 |
| #422 |
Melissa B. Galfano |
— |
1 |
| #422 |
Guoying Bing |
New York University |
1 |
| #422 |
Audrey S. Raphael |
— |
1 |
| #422 |
Harry J. Regis |
AT&T |
1 |
| #422 |
Stewart C. Raphael |
— |
1 |
| #422 |
Osvaldo E. Vagani |
— |
1 |
| #422 |
Richard C. Tio |
— |
1 |
| #422 |
Steven P. Kramer |
Oncogene Science |
1 |
| #422 |
Alexander Mencher |
— |
1 |
| #422 |
Evelyn Holmes |
— |
1 |
| #422 |
Madhav N. Damle |
— |
1 |
| #422 |
Moshe Zangilbaf |
— |
1 |
| #422 |
Claudia P. Holtz |
— |
1 |
| #422 |
Paul Lupoli |
— |
1 |